Long-term influence of oestrogen plus progestin vs oestrogen alone on breast cancer incidence in post-menopausal women
Published: 19 Dec 2019
Views: 498
Prof Rowan Chlebowski - City of Hope National Medical Center, Duarte, USA
Prof Rowan Chlebowski gives a press conference at the 2019 San Antonio Breast Cancer Symposium about the long-term influence of oestrogen plus progestin versus oestrogen alone on breast cancer incidence in post-menopausal women.
Watch our interview with Prof Chlebowski here
Read more about the study here
Related Videos
Highlights from EBCC-12
Prof Nadia Harbeck - EBCC Conference Chair
23 Oct 2020
COVID-19 and breast cancer: How should we treat our patients?
Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain
12 Jun 2020
Ensuring quality care for breast cancer patients globally
Dr Didier Verhoeven - University of Antwerp, Antwerp, Belgium
1 Jun 2020
Diagnosing, treating and managing breast cancer during COVID-19
Prof Philip Poortmans - University of Antwerp, Antwerp, Belgium
22 May 2020
How can we implement breast cancer screening India?
Dr Sanjit Agarwal - Tata Medical Center, Kolkata, India
9 Mar 2020
Advances in breast cancer treatment over the last 20 years
Dr Philip Poortmans - Institut Curie, Paris, France
27 Jan 2020
An overview of breast cancer in Malaysia
Prof Cheng-Har Yip - Subang Jaya Medical Centre, Kuala Lumpur, Malaysia
27 Jan 2020
The challenges of treating breast cancer in Brazil
Dr Felipe Ades - Hospital Alemão Oswaldo Cruz, São Paulo, Brazil
19 Dec 2019
Implementation of genetic testing in breast cancer patients
Dr Nadine Tung - Beth Israel Deaconess Medical Center, Boston, USA
19 Dec 2019
